Charged Alpha Stock Encyclopedia

Canadian National Railway (CNI) Q2 2026 — Canadian National Railway (CNI on the NYSE, CNR on the TSX) — the only railroad whose network reaches three coasts and one of North America's premier franchises — reported a Q2 2026 beat-and-raise (all figures in Canadian dollars, US GAAP): adjusted diluted EPS of C$2.08 beat the ~C$1.93 estimate (+11% YoY; reported EPS C$2.06, +10%) on revenue of C$4.75B (+11%), operating income of C$1.78B (+9%) and net income of C$1.25B. But the marquee operating ratio ROSE 80 bps to 62.5% (adjusted 62.2%) — the beat came from volume (RTMs +5%) and pricing (freight revenue/RTM +6%, revenue/carload +12% to C$3,236), not efficiency, as diesel prices jumped ~60% (C$5.67 vs C$3.55/gal) and swamped a fuel-efficiency record. Carloads were flat (1.41M). Grain & fertilizers (+18%), petroleum & chemicals (+16%) and automotive (+18%) led; coal was flat. CN RAISED full-year guidance (RTM growth flat to low-single-digit; adjusted EPS growth to mid-to-high single digit), kept ~C$2.8B capex, grew first-half free cash flow 19% to C$1.84B, tripled first-half buybacks to C$1.32B, and raised the dividend to C$0.9150/quarter. Yet on the NYSE line the stock (~US$129, near its US$131.51 52-week high, ~23x forward earnings) sits above our owner-earnings DCF fair value of ~US$118 (C$ cash flows converted at US$0.71/C$) — and above even Wall Street's ~US$119 average target. Our call: HOLD, 3/5. Not financial advice.

Canadian National Railway is one of the widest-moat businesses in North America — a transcontinental railroad whose nearly 19,000-mile network is the only one reaching three coasts (Canada's Atlantic and Pacific, and the U.S. Gulf), moving over 300 million tons a year. A key note up front: CN reports in Canadian dollars, while its NYSE line (CNI) trades in U.S. dollars at ~71 US cents per C$1. Q2 2026 was a genuinely good quarter: adjusted diluted EPS of C$2.08 beat the ~C$1.93 estimate (+11% YoY), revenue rose 11% to C$4.75B, and management RAISED full-year guidance (volume growth flat to low-single-digit; adjusted EPS growth to mid-to-high single digit). But here's the nuance the headlines miss: the marquee operating ratio actually ROSE 80 bps to 62.5% (higher is worse). The beat came from volume (revenue ton-miles +5% on a strong grain crop and booming energy) and pricing (freight revenue/RTM +6%, revenue/carload +12%), NOT efficiency — a ~60% jump in diesel prices swamped a genuine fuel-efficiency record, and carloads were actually flat, so the growth was mix, not more shipments. CN's cash machine impressed: first-half free cash flow +19% to C$1.84B, buybacks tripled to C$1.32B, dividend raised to C$0.9150/quarter. So the debate isn't quality — it's price. The NYSE line has recovered ~43% off its US$90.74 low to ~US$129, near its US$131.51 record, at ~23x forward earnings. Converting CN's C$ owner earnings (a ~C$4.0B normalized base) at US$0.71, our owner-earnings DCF lands fair value near US$118 — below the price, even on the optimistic pricing-and-productivity path. Strikingly, even Wall Street's average target (~US$119) now sits below the stock. Our call: HOLD, 3/5 — a premier franchise with no margin of safety, and hard grain comps looming in Q4. Own it for the quality; add on real weakness toward the US$110s (C$150s). Not financial advice.

THE CALL: HOLD (3/5, A PREMIER FRANCHISE AT A FULL PRICE — A BEAT-AND-RAISE WITH NO MARGIN OF SAFETY) — base-case value ~$118 vs ~$129 today.

What to watch: evidence the growth is broadening beyond grain and energy — sustained, well-served volume gains that aren't just a strong crop — together with the operating ratio grinding back toward the low 60s as diesel prices normalize, which would justify the premium multiple and prompt an upgrade; the risks to respect are the grain tailwind fading into hard fourth-quarter comps (CN laps a record crop and only assumes an average one next season), cross-border tariffs and trade tensions biting freight volumes, and a weak Canadian dollar plus elevated fuel squeezing margins — any of which, near a 52-week high at ~23x forward earnings, could re-rate the stock

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

World Kinect (WKC) Q2 2026 — World Kinect (WKC), the global fuel-logistics distributor formerly known as World Fuel Services, reported a record Q2 2026: adjusted EPS of $1.29 crushed the ~$0.75 estimate (a 72% beat and the best quarter in company history) on revenue of $13.6B (+50% YoY) and all-time-record consolidated gross profit of $350M (+50%). Adjusted EBITDA was $135.7M (beat by ~40%); GAAP EPS was $0.94. The beat was powered by a fuel-price-volatility windfall tied to Middle East tensions — Aviation gross profit hit a record $208M (+51%) on physical-inventory gains, and Marine nearly tripled to ~$80M — even as volumes fell ~7.5% and free cash flow was negative (-$35M). Management RAISED full-year adjusted-EPS guidance to $3.20-$3.40 (from $2.65-$2.85). The stock soared ~13% to a 52-week high near $39 (up ~66% YTD), blowing past every Wall Street target (avg ~$29, high $33). Normalizing for the windfall, our fair value is ~$35. Our call: HOLD.

World Kinect (WKC) — the ~$2B fuel-and-energy logistics distributor formerly called World Fuel Services — just posted the best quarter in its history. Adjusted EPS of $1.29 nearly doubled the ~$0.75 estimate (a 72% beat), revenue jumped 50% to $13.6B, and consolidated gross profit set an all-time record at $350M. The stock soared ~13% to a fresh 52-week high near $39 (up ~66% YTD). But here's the tension: this is a razor-thin-margin distributor (operating margin under 1%), and the blowout was powered largely by a fuel-price-volatility windfall from Middle East tensions — Aviation gross profit hit a record $208M (+51%) on physical-inventory gains, and Marine nearly tripled to ~$80M, even as fuel volumes FELL ~7.5% and free cash flow was NEGATIVE (-$35M). Management raised full-year adjusted-EPS guidance to $3.20-$3.40, but even that banks the hot quarter without annualizing it. Because cash flow here swings wildly with fuel prices, we value WKC on normalized earnings power (~$2.75/share, stripping out the windfall) times a fair low-teens multiple, cross-checked with EV/EBITDA (~6.5x). That lands fair value near $35 — a bit below today's ~$39, which has now run past every Wall Street price target (avg ~$29, high $33). Our call: HOLD, 3/5. A well-run operator and a genuinely good aviation franchise, but a great quarter is not the same as a great business — don't chase a one-time windfall. Not financial advice.

THE CALL: HOLD (3/5, A RECORD WINDFALL QUARTER, ALREADY IN THE PRICE — A BLOWOUT DRIVEN BY FUEL-PRICE VOLATILITY THAT FADES) — base-case value ~$35 vs ~$39 today.

KEY METRICS:

- Adjusted EPS $1.29 beat ~$0.75 estimate (+72%) — a company-record quarter; GAAP EPS $0.94

- Revenue $13.6B (+50% YoY), beat ~$10.6B estimate by ~28%

- Consolidated gross profit $350M (+50% YoY) — an all-time quarterly record

- Aviation gross profit $208M (+51%) — segment record, on physical-inventory gains from jet-fuel volatility

- Marine gross profit ~$80M (nearly tripled YoY); marine volume 3.5M metric tons (-10% YoY)

- Land gross profit ~$62M (derived) — steadier diesel + sustainability / energy-management

- Adjusted EBITDA $135.7M (beat by ~40%); operating profit $96.1M (0.7% operating margin)

- Free cash flow -$35.1M (vs +$13.3M a year ago); total volumes -7.5% YoY

- FY2026 adjusted EPS guidance RAISED to $3.20-$3.40 (from $2.65-$2.85)

- Net debt ~$610M (total debt $745M, cash $135M); equity ~$1.26B; ~9% of shares repurchased recently

- Valuation: stock ~$39 (+13% on the print, +66% YTD, 52-wk high ~$41); ~$2.0B market cap; EV ~$2.6B; ~6.5x normalized EV/EBITDA

What to watch: two or three quarters of higher NORMALIZED gross profit even after fuel-price volatility fades — plus continued aggressive buybacks — would confirm a genuinely higher earnings baseline and could justify a re-rating and an upgrade; the risk to respect is the obvious one, fuel markets calming so the physical-inventory gains reverse and earnings mean-revert toward ~$2.75 normalized EPS — so watch fuel-price volatility and the volume trend every quarter

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Verizon Communications (VZ) Q2 2026 — Verizon Communications (VZ) reported a strong Q2 2026: adjusted EPS of $1.30 beat the ~$1.27 estimate (+6.6% YoY) and management RAISED full-year guidance for the second straight quarter (adjusted EPS to $4.99-$5.04, free cash flow growth to 9-10%). Total revenue was $34.3B (-0.7% YoY as equipment fell ~20% on lower upgrades), but service revenue grew 3.5%, adjusted EBITDA hit a record $13.7B at a record 40.1% margin, and Verizon added 184,000 postpaid phone customers — its best Consumer Q2 in five years and a swing from a loss a year ago — with churn down to 0.92%. Q2 free cash flow jumped 24% to $6.4B, funding a ~6% dividend (about 19 straight years of raises, covered ~1.9x by FCF). The stock popped ~5% to ~$46, yet still trades at ~9x earnings and an ~11% free-cash-flow yield with $128.7B of net debt (2.5x). Our owner-earnings / DCF pegs fair value near $58 — about 25% above the price. Our call: BUY.

Verizon is maybe the most unloved blue chip in America — a ~$192B wireless giant so out of favor it yields almost 6%, trades at ~9x earnings, and gets written off as a slowly melting ice cube. But Q2 2026 was the quarter the bears did not see coming: Verizon added 184,000 postpaid phone customers (its best Consumer Q2 in five years, versus a loss a year ago), churn fell to 0.92%, adjusted EBITDA hit a record $13.7B at a record 40.1% margin, free cash flow jumped 24% to $6.4B, and — for the second straight quarter — management RAISED full-year guidance (adjusted EPS to $4.99-$5.04, FCF growth to 9-10%, about $22B). New CEO Dan Schulman's transformation — simpler plans, a converged Verizon-One bundle, a loyalty program, and the newly closed Frontier fiber acquisition (~30M homes) — is showing up in the numbers. The ~6% dividend (about 19 straight years of raises) is covered ~1.9x by free cash flow. The catch: $128.7B of net debt (2.5x adjusted EBITDA, up after Frontier) and a still-flat top line. Even so, our conservative owner-earnings / FCF-DCF lands fair value near $58 — about 25% above the ~$46 price — and we are modestly ABOVE the Street's ~$50 average. Our call: BUY, 4/5. Not financial advice.

THE CALL: BUY (4/5, CHEAP, HATED, AND FINALLY TURNING — A BEAT-AND-RAISE THE STREET DOESN'T BELIEVE YET) — base-case value ~$58 vs ~$46 today.

KEY METRICS:

- Adjusted EPS $1.30 beat ~$1.27 estimate (+6.6% YoY); GAAP EPS $0.92 (on ~$1.8B one-time charges)

- Total revenue $34.3B (-0.7% YoY); service revenue +3.5%; wireless equipment revenue -20%

- Postpaid phone net adds 184K — best Consumer Q2 in 5 years, vs a ~9K loss a year ago

- Postpaid phone churn 0.92% (near record low); broadband net adds 348K (193K fixed wireless + 155K fiber)

- Adjusted EBITDA $13.7B (+7.2%), a record; adjusted EBITDA margin 40.1%, a record

- Q2 free cash flow $6.4B (+24.4%); first-half FCF $10.2B (+16%)

- FY26 guidance RAISED (2nd straight quarter): adjusted EPS $4.99-$5.04, FCF growth 9-10% (~$22B)

- Dividend $0.7075/qtr (~6% yield), ~19 straight years of increases, covered ~1.9x by FCF

- Net unsecured debt $128.7B (2.5x adjusted EBITDA); Frontier fiber acquisition closed (~30M homes)

- Buyback raised to up to $4.5B; $9.4B total capital returned to shareholders in first half

- Valuation: ~9x forward earnings, ~11% FCF yield, ~6.5x EV/EBITDA; stock +5% on the print to ~$46

What to watch: two or three more quarters of low churn and positive postpaid phone net adds, plus visible debt paydown, would confirm the turnaround's durability and justify a re-rating toward the high $50s and beyond; the risk to respect is a renewed three-way price war with AT&T and T-Mobile that spikes churn and reverses the margin gains — so watch churn and net adds every quarter

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

NextEra Energy (NEE) Q2 2026 — NextEra Energy (NEE), the largest U.S. electric utility and the world's biggest generator of wind and solar, reported a solid Q2 2026 on July 24: adjusted EPS of $1.15 beat the ~$1.10 estimate (+9.5% YoY), though revenue of $7.53B missed the ~$8.0B consensus. Florida Power & Light earned $1.41B ($0.67/sh) as its regulated rate base grew 9.3%; NextEra Energy Resources earned $1.29B adjusted ($0.62/sh) and signed another 3.6 GW of renewables/storage (incl. 2 GW batteries), lifting its backlog to ~35 GW. Management reaffirmed FY2026 adjusted EPS of $3.92-$4.02 (targeting the top end) and >8%/yr long-range EPS growth through 2032 — but slowed dividend growth to ~6% (from ~10%) to help fund the pending, transformational Dominion Energy merger. The stock (~$89, roughly flat on the print) trades at ~22x forward earnings, a premium to peers. Our blended P/E + dividend-discount fair value lands near $90 — essentially the price. Our call: HOLD, 3/5 — a notch below the Street's ~$99 Buy.

NextEra Energy is the bluest of blue-chip utilities — the largest electric utility in America and the world's number-one generator of wind and solar, built on two engines: Florida Power & Light, the gold-standard regulated utility serving ~12M Floridians, and NextEra Energy Resources, the world's leading clean-power developer. Q2 2026 (reported July 24) was a solid quarter: adjusted EPS of $1.15 beat the ~$1.10 estimate (+9.5% YoY) and GAAP EPS was $1.50, though revenue of $7.53B came in light versus the ~$8.0B consensus. FPL earned $1.41B ($0.67/sh) on 9.3% rate-base growth; Resources earned $1.29B adjusted ($0.62/sh) and added 3.6 GW to its renewables/storage backlog (incl. 2 GW of batteries), pushing the pipeline to ~35 GW. Management reaffirmed FY2026 adjusted EPS guidance of $3.92-$4.02 — and said it expects the top end — plus a long-range plan of >8%/yr adjusted-EPS growth through 2032. The catch: it's underwriting the biggest merger in utility history, the pending acquisition of Dominion Energy (announced May 2026, ~12-18 months to close), which also slows dividend growth from ~10% to ~6% a year. At ~$89 the stock trades near 22x forward earnings — a clear premium to the 17-18x utility average — with net debt near 6x EBITDA and a ~2.8% yield. Because a capex-heavy regulated + clean-energy utility runs free cash flow negative by design, we value NEE on a utility frame: a fair P/E (20-22x on 2026-27 EPS) plus a two-stage dividend-discount model. Both cluster near $90 — essentially today's price, i.e., no margin of safety. Our call: HOLD, 3/5. A best-in-class utility, fully priced, taking on enormous change — and we're a notch more cautious than the Street's Buy (~$99 avg, 24 of 36 analysts). We'd add on real weakness in the mid-$80s and watch the Dominion regulatory calendar closely. Do your own research; this is not financial advice.

THE CALL: HOLD (3/5, A BEST-IN-CLASS UTILITY, FULLY PRICED — A BEAT WITH NO MARGIN OF SAFETY, NOW UNDERWRITING A MEGA-MERGER) — base-case value ~$90 vs ~$89 today.

What to watch: clean progress on the Dominion merger — key state and federal regulatory approvals landing without painful concessions — which would lift the single biggest overhang and could prompt an upgrade; the risks to respect are the merger bogging down in the states or the balance sheet straining and pressuring the dividend, and at ~22x forward earnings with no margin of safety even a modest stumble could re-rate the premium multiple lower

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

The Vita Coco Company (COCO) Q2 2026 — The Vita Coco Company (COCO), the #1 coconut-water brand, reported a blowout Q2 2026: EPS of $0.82 crushed the ~$0.55 estimate (+116% YoY) on net sales of $216M (+28%), gross margin of 49% (vs 36% a year ago), and adjusted EBITDA of $67M (+$38M). Management RAISED full-year 2026 guidance (net sales $790–805M, adjusted EBITDA $154–161M) and announced the $175M acquisition of super-premium coconut-water maker Copra. Yet the stock gapped up over 7% at the open and then faded all day to close down ~6.8% at ~$69. The catch: ~700bps of that 49% gross margin came from one-time tariff refunds, ocean freight (the key margin swing factor) is cyclically low, and after roughly tripling off its $32 low the stock trades ~24x EV/EBITDA and ~38x earnings. Our owner-earnings DCF lands fair value near $62 — below the price. Our call: HOLD, 3/5.

The Vita Coco Company is the little brand that built the modern coconut-water category — and it's still the #1 brand in the U.S. and globally, an asset-light, net-cash, founder-led compounder growing fast. Q2 2026 was a blowout on the headline: EPS of $0.82 crushed the ~$0.55 estimate (+116% YoY), net sales rose 28% to $216M, gross margin jumped to 49% from 36%, adjusted EBITDA rose $38M to $67M, and management RAISED full-year guidance (net sales $790–805M, adj EBITDA $154–161M) while announcing a $175M deal for super-premium Copra. So why did the stock gap up 7% and then fade to close down ~7%? Because the beat was partly borrowed. Management disclosed that ~700 basis points of the 49% gross margin came from one-time tariff refunds — strip them out and underlying margin was ~42%. The rest leaned on cyclically low ocean freight, the single biggest swing factor in Vita Coco's margin. Underneath, demand is real (case volumes +15% Coconut Water, +78% Private Label; International +63%), and the balance sheet is a fortress — but the $175M Copra deal cuts pro-forma net cash from ~$266M to ~$90M. After tripling off its $32 low to ~$69, the stock trades ~24x EV/EBITDA and ~38x earnings. Our normalized owner-earnings DCF (base ~$115M/yr, 8%→16% growth paths) lands fair value near $62 — about 11% below the price, and a reverse-DCF shows $69 requires ~mid-teens owner-earnings growth for a decade. A wonderful business with no margin of safety. Our call: HOLD, 3/5. We're more cautious than the Street's bullish ~$78 average target (Buy, 9 of 15 analysts — but 3 outright sells). Own it for the quality, add in the mid-$50s, and watch ocean freight above all. Not financial advice.

THE CALL: HOLD (3/5, A CATEGORY WINNER, PRICED FOR PERFECTION — A BIG BEAT PARTLY FLATTERED BY ONE-TIME TARIFF REFUNDS) — base-case value ~$62 vs ~$69 today.

What to watch: evidence the margin is durable as the one-time tariff refunds roll off — ocean freight staying low, pricing sticking, Copra integrating accretively, and International compounding — which would justify the premium multiple and prompt an upgrade; the risk to respect is ocean freight re-inflating (the single biggest margin swing factor) or volume growth stalling, which at ~24x EV/EBITDA and ~38x earnings could re-rate the stock hard

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

Quest Diagnostics (DGX) Q2 2026 — Quest Diagnostics (DGX), one of the two national giants of U.S. lab testing, reported a strong Q2 2026: adjusted EPS of $3.12 beat the ~$2.82 estimate (+19.1% YoY) on revenue of $3.04B (+10.2%), with 10.0% ORGANIC growth; reported GAAP EPS was $2.84 (+15%). The engine was pure volume — requisitions rose 13.1% (organic +13.0%) — while revenue per requisition fell 2.8%, so adjusted operating margin slipped to 16.5% (from 16.9%). Management RAISED full-year 2026 guidance again — adjusted EPS to $11.05–$11.25, revenue to $11.95–$12.05B, and operating cash flow to ~$1.80B. The stock jumped ~8.6% on the print to a fresh 52-week high (~$238 intraday), closing near $228, up from a $166 low. At ~20x forward EPS, our owner-earnings DCF lands fair value near $250 — above the price and above the Street's ~$232 Hold target. Our call: BUY, 4/5.

Quest Diagnostics is the boring, defensive backbone of American lab testing — a ~$25B company that runs the blood, urine, and molecular tests your doctor orders, serving half of U.S. physicians and hospitals and one in three adults a year, led by CEO Jim Davis. For years the market has treated it as a slow, low-growth compounder that buys its growth by acquiring smaller labs. Q2 2026 quietly challenged that: adjusted EPS of $3.12 beat the ~$2.82 estimate (+19.1% YoY), revenue rose 10.2% to $3.04B — and critically, 10.0% of that was ORGANIC, from the existing business, not deals. Test volume (requisitions) jumped 13.1% (organic +13.0%) across physician, hospital, and consumer channels, with double-digit gains in high-value Advanced Diagnostics (Alzheimer's AD-Detect blood tests, Haystack MRD molecular cancer testing, cardiometabolic panels). Management RAISED full-year guidance again — adj EPS to $11.05–$11.25, revenue to $11.95–$12.05B, OCF to ~$1.80B — and the stock popped ~8.6% to a new 52-week high near $228. The honest catch: it's ALL volume — revenue per requisition fell 2.8% and adjusted operating margin slipped to 16.5% from 16.9%, so automation and AI (robotics in screening, smart specimen routing) must cut cost per test faster than reimbursement cuts price. On owner earnings of ~$1.25B/yr (FCF ≈ adjusted net income), our DCF lands fair value near $250 — about 10% above the ~$228 price — and, crucially, even the conservative steady-growth path lands ~$232, right at today's price, so the downside is protected. That's above the Street's lukewarm ~$232 Hold target (roughly 13 buys / 18 holds / 3 sells). Our call: BUY, 4/5 — a quality, defensive compounder growing double digits at ~20x earnings, and we're more bullish than Wall Street. We'd scale in after the pop and add on any dip toward the low $200s, watching organic volume and the operating margin every quarter. Not financial advice.

THE CALL: BUY (4/5, THE 'SLEEPY LAB' IS QUIETLY COMPOUNDING — 10% ORGANIC GROWTH, A RAISED GUIDE, AND STILL PRICED NEAR 20x EARNINGS) — base-case value ~$250 vs ~$228 today.

What to watch: hard evidence that automation and mix are converting the volume surge into profit — adjusted operating margin turning back up while organic volume stays strong — which would prove the acceleration is durable and push our fair value higher; the risk to respect is a step-down in reimbursement or the volume surge fading so revenue per requisition keeps falling with nothing to offset it, capping earnings and the multiple. Watch two numbers every quarter: organic requisition volume and the adjusted operating margin.

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

HCA Healthcare (HCA) Q2 2026 — HCA Healthcare (HCA), the largest for-profit hospital operator in the U.S., delivered a headline-beating Q2 2026 — then CUT its full-year guidance. Q2 diluted EPS of $7.62 rose ~12% YoY (vs $6.83) on revenue of $20.23B (+8.7%) and adjusted EBITDA of $4.03B (+4.6%) — but the adjusted EBITDA margin compressed from 20.7% to 19.9%, and management LOWERED FY2026 guidance (EPS to $28.70–$30.50, net income to $6.3–$6.7B, adj EBITDA to $15.4–$16.1B), citing a worsening uninsured/payer-mix headwind now pegged at $1.0–$1.2B. A one-time ~$400M Florida Medicaid Supplemental catch-up roughly offset a ~$400M uninsured hit this quarter, flattering the print. The stock had already fallen ~32% from its $556 high to ~$377 (~13x earnings, ~9% FCF yield) and dropped ~7% on the July 14 preannouncement. Our leverage-adjusted owner-earnings DCF lands fair value near $400 — modestly above the price — and a buyback that has shrunk the share count ~20% in three years compounds per-share returns. Our call: BUY, 3/5.

HCA Healthcare is the #1 for-profit hospital operator in America — a genuine fortress, running ~190 hospitals and 2,500+ sites of care across 20 states and the UK, led by CEO Sam Hazen — caught in a genuinely tricky moment. Q2 2026 looked strong on the surface: diluted EPS of $7.62 jumped ~12% YoY (vs $6.83), revenue rose 8.7% to $20.23B, and adjusted EBITDA reached $4.03B. But one layer down it sours: the adjusted EBITDA margin compressed from 20.7% to 19.9%, and management CUT full-year guidance — EPS to $28.70–$30.50, net income to $6.3–$6.7B, adj EBITDA to $15.4–$16.1B — as the uninsured/payer-mix headwind was revised WORSE, to $1.0–$1.2B for 2026. The root cause is policy: the enhanced ACA premium tax credits expired end-2025 and the new federal budget law is tightening Medicaid, pushing more patients into the uninsured bucket, with a bigger 2027 'cliff' the key risk. The quarter itself was flattered by a one-time ~$400M Florida Medicaid Supplemental catch-up that roughly offset a ~$400M uninsured hit. So why are we buyers? Because the market has already done a lot of the punishing: the stock fell ~32% from its $556 high to ~$377 (~13x earnings, ~9% FCF yield — the cheapest in years), and dropped ~7% on the July 14 preannouncement. Volumes are still healthy (same-facility admissions +2.5%, ER visits +3.6%), and a relentless buyback has cut the share count ~20% in three years — the real per-share growth engine, funded partly with debt on a leveraged, negative-book-equity balance sheet (~$49B net debt, 3.1x EBITDA). Our leverage-adjusted owner-earnings DCF (9/10/11% discount) lands fair value near $400 — modestly above the price — and the freshest post-preannouncement Street targets (Wells Fargo $369, BofA $370, Barclays $402) cluster right on it, even as a stale consensus average near $482 hasn't caught up. Our call: BUY, 3/5 — a de-rated cash machine where the fear is mostly priced in. Modest conviction, because the 2027 uninsured cliff is a real risk and this cut may not be the last. Add on the dips it keeps handing you in the $330s, and watch the 2027 guidance like a hawk. Not financial advice.

THE CALL: BUY (3/5, A DE-RATED CASH MACHINE — A HEADLINE BEAT, A GUIDANCE CUT, AND THE FEAR MOSTLY PRICED IN) — base-case value ~$400 vs ~$377 today.

What to watch: evidence the uninsured/payer-mix headwind is stabilizing rather than compounding — a 2027 outlook that holds, Medicaid supplemental programs proving durable, and margins bottoming — which would justify an upgrade toward 4/5; the risk to respect is the 2027 EPTC/health-insurance-exchange cliff deepening the uninsured hit (making this year's guidance cut a down-payment on a bigger one), or heavy leverage (~$49B net debt, 3.1x EBITDA, negative book equity) forcing the buyback to slow

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

TotalEnergies SE (TTE) Q2 2026 — TotalEnergies (TTE), the French supermajor and NYSE-listed ADR (1 ADR = 1 ordinary share), reported a blowout Q2 2026: adjusted net income surged 68% YoY to $6.0B and adjusted EPS hit $2.68 per ADR (beat ~$2.66, +71% YoY), on $9.8B of cash flow from operations (+48%) and $13.2B adjusted EBITDA (+27%). The engine was a commodity windfall — Brent averaged ~$104 (+53% YoY) and refining margins nearly tripled — while hydrocarbon production actually fell 4% to 2.4 Mboe/d and Integrated LNG profit dropped 22%. The balance sheet is a fortress (gearing just 13%, net debt ~$19.7B), funding a dividend raised 5.9% and ~$6B/yr of buybacks — a ~7.5% shareholder yield. At ~$86, TTE trades ~9x forward earnings and ~5.4x EV/EBITDA. Even normalizing the oil peak to mid-cycle, our owner-earnings DCF lands fair value ~$95/ADR. Our call: BUY, 4/5.

TotalEnergies is one of the world's five Western supermajors — a ~$190B French integrated energy giant spanning oil & gas production, a top-three global LNG business, refining & chemicals, thousands of service stations, and, unusually for Big Oil, a fast-growing Integrated Power arm in renewables and electricity that hedges the energy transition. Q2 2026 was a blowout: adjusted net income +68% YoY to $6.0B, adjusted EPS $2.68 per ADR (+71% YoY, beat ~$2.66), CFFO $9.8B (+48%), adjusted EBITDA $13.2B (+27%), ROE ~16%, gearing cut to 13%. But be honest about the driver — this was a commodity windfall: Brent averaged ~$104 (+53% YoY) on Middle East supply disruption, and TotalEnergies' European refining-margin marker nearly tripled to $13.5/bbl. Segment adjusted operating income: Exploration & Production $3.2B (+64%), Refining & Chemicals $1.8B (x4.6), Marketing & Services $0.5B (+21%), Integrated LNG $0.8B (-22%), Integrated Power $0.5B. Underneath the windfall the base business is flat-to-declining — production fell 4% to 2.4 Mboe/d and LNG softened once you strip out the oil price. The bull case is value plus capital return: ~9x forward earnings, ~5.4x EV/EBITDA, a fortress balance sheet (gearing 13%, net debt ~$19.7B), a dividend raised 5.9% (never cut, even in the 2020 crash) and ~$1.5B/quarter of buybacks — together a ~7.5% shareholder yield. Even after normalizing this quarter's ~$100 oil back to a sober mid-cycle price, our owner-earnings DCF lands fair value near $95/ADR — modest upside from ~$86, plus that fat, well-covered yield. Our call: BUY, 4/5 — a cheap, fortress-balance-sheet major paying you to wait — but it's a commodity cyclical printing peak earnings, so size it as one, not as a steady compounder. We're aligned with the Street's Buy consensus (~$100 average target, ~34 analysts), just a touch more conservative on the cycle. Add on oil-driven dips into the high $70s, and watch the Integrated Power ramp and the LNG market. Not financial advice.

THE CALL: BUY (4/5, A CHEAP, FORTRESS-BALANCE-SHEET SUPERMAJOR PAYING YOU 7.5% TO WAIT — MIND THE COMMODITY CYCLE) — base-case value ~$95 vs ~$86 today.

What to watch: hard evidence the Integrated Power business is scaling into real, growing profit while oil holds a healthy range — a less-cyclical earnings stream that could finally re-rate an oil major's stubbornly low multiple and prompt an upgrade; the risk to respect is Brent sliding back into the $60s and staying there, which would squeeze cash flow, pressure the ~$6B/yr buyback, and turn today's cheap multiple expensive on shrunken, normalized earnings

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

United Rentals (URI) Q2 2026 — United Rentals (URI), the world's largest equipment-rental company, reported a record Q2 2026: adjusted EPS of $12.76 beat the ~$11.55 estimate (+22% YoY) on record revenue of $4.41B (+12%), with rental revenue up 12.7% to $3.85B and adjusted EBITDA of $2.06B at a 46.6% margin. Specialty rentals surged ~25%, fleet productivity rose 3.4%, and management RAISED full-year 2026 guidance — revenue to $17.5–$17.8B and adjusted EBITDA by ~$300M to ~$8.05B. The stock jumped ~10.7% to an all-time high near $1,140, up ~62% off its 52-week low of ~$702. The catch: at ~22x forward earnings and only a ~3% free-cash-flow yield (FCF guidance was left unchanged at $2.15–$2.45B as capex rose to fund fleet growth), our owner-earnings DCF lands fair value near $950 — below the price. Our call: HOLD.

United Rentals is one of the great industrial compounders of the last decade — the world's largest equipment-rental company, renting boom lifts, generators, pumps, trench boxes and power systems out of 1,500+ locations across North America, roughly twice the size of its nearest rival. Q2 2026 was a genuinely great quarter: adjusted EPS of $12.76 beat the ~$11.55 estimate (+22% YoY), revenue set a record at $4.41B (+12%), adjusted EBITDA hit $2.06B at a 46.6% margin, and management RAISED full-year guidance again (revenue to $17.5–$17.8B, adjusted EBITDA +~$300M to ~$8.05B). The engine was Specialty Rentals, up ~25% across every line on powerful data-center, chip-fab and infrastructure demand. So the debate isn't quality — it's price. The stock jumped ~10.7% on the print to an all-time high near $1,140, up ~62% off its 52-week low, and now trades near 22x forward earnings — well above its historical low-to-mid-teens multiple — at just a ~3% free-cash-flow yield. Note the tell: management did NOT raise free-cash-flow guidance ($2.15–$2.45B), because they raised capex to fund growth, so the cash reaching owners isn't rising with EBITDA. Even crediting a durable super-cycle, our owner-earnings DCF (base ~$2.6B, 9% discount) lands fair value near $950 — below the price. A best-in-class operator with no margin of safety. Our call: HOLD, 3/5. We're more cautious than the Street's Buy rating and ~$1,144 average target — which, after the pop, the stock has already reached. Own it for the quality, add on real weakness toward the $900s, and watch the construction cycle. Not financial advice.

THE CALL: HOLD (3/5, A BEST-IN-CLASS OPERATOR AT A PEAK-CYCLE PRICE — A RECORD BEAT-AND-RAISE WITH NO MARGIN OF SAFETY) — base-case value ~$950 vs ~$1140 today.

KEY METRICS:

- Adjusted EPS $12.76, beat ~$11.55 (+22% YoY); GAAP EPS $12.03

- Record revenue $4.41B (+12%); rental revenue $3.85B (+12.7%)

- Adjusted EBITDA $2.06B at a 46.6% margin (a $49M scaffolding-sale gain flattered it; ex-gain margin fell ~40 bps)

- Specialty rentals +25%; General rentals +6.6%; fleet productivity +3.4%

- FY2026 guidance raised: revenue $17.5–$17.8B, adjusted EBITDA ~$8.05B (+~$300M)

- Free cash flow guidance UNCHANGED at $2.15–$2.45B as gross capex rose to ~$4.85–$5.25B

- Net leverage 1.8x; ROIC 11.8%; $1.5B buybacks planned in 2026; ~$7.88 annual dividend

- Street: Buy (29 buy / 7 hold / 5 sell, 41 analysts); avg target ~$1,144 vs ~$1,140 price

- Our fair value ~$950 (owner-earnings DCF, 9% discount) — ~17% below price

What to watch: hard evidence this construction super-cycle is long and durable — specialty growth holding above 20%, fleet productivity accelerating, and free cash flow finally inflecting higher as capital spending normalizes — which would justify the premium multiple and prompt an upgrade; the risk to respect is the construction cycle rolling over (rental rates softening, utilization falling, mega-projects delayed), which at ~22x earnings and a peak-cycle multiple could re-rate the stock hard

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.

T-Mobile US (TMUS) Q2 2026 — T-Mobile US (TMUS), America's postpaid wireless leader, reported a strong Q2 2026: diluted EPS of $2.99 beat the ~$2.60 estimate (+5% YoY), Core Adjusted EBITDA rose 12% to $9.5B, total service revenue grew 9% to $19.0B (industry-leading), and Adjusted Free Cash Flow was $4.8B — and management RAISED full-year cash guidance (Adjusted FCF to $18.4–$18.8B, operating cash flow to $28.4–$28.8B). Postpaid phone net adds of 777K led the industry (0.80% phone churn) and 5G home broadband added 406K. Yet the stock CRASHED ~10.7% to $170.42 — near its 52-week low, ~35% off its $261.56 high — because total revenue of $22.79B slightly missed, postpaid account adds slowed 13% to 277K, and it was the first quarter in ages without an across-the-board guidance raise. Priced for perfection, it delivered merely excellent. After the crash the stock trades at ~9x FCF, ~6.9x EV/EBITDA and a ~10% FCF yield. Our call: BUY, 4/5, fair value ~$230.

T-Mobile US is the un-carrier — the disruptor that stormed from number three to America's number-one postpaid wireless company, and after absorbing Sprint it runs the deepest 5G network in the country (a record NPS of 46 and a clean sweep of the independent network awards). Q2 2026 was a genuinely good quarter: diluted EPS of $2.99 beat (~+5% YoY), total service revenue rose 9% to $19.0B (industry-leading), postpaid service revenue jumped 13% to $15.9B, Core Adjusted EBITDA grew 12% to $9.5B, and Adjusted Free Cash Flow hit $4.8B. Postpaid PHONE net adds of 777K led the entire industry with phone churn of just 0.80%, and 5G home broadband added 406K. Management even RAISED full-year cash guidance — Adjusted FCF to $18.4–$18.8B and operating cash flow to $28.4–$28.8B — while reiterating account growth (950K–1.05M) and Core EBITDA ($37.1–$37.5B). And yet the stock fell almost 11% to ~$170, near a 52-week low: total revenue of $22.79B came up a hair light, postpaid ACCOUNT adds slowed 13% to 277K (churn up to 0.99% on a broadband-only mix and a coming rate-plan reset), and — for the first time in ages — guidance didn't rise across the board. A stock priced for perfection delivered merely excellent, and got punished. The catch now cuts the other way: after a ~35% drawdown, TMUS trades at ~9x free cash flow, ~6.9x EV/EBITDA and a ~10% FCF yield, with an aggressive buyback shrinking the share count ($3.3B returned in Q2, $54.6B since 2022). Our owner-earnings DCF — conservatively haircutting the ~$18.6B FCF guide to ~$15.5B of sustainable owner earnings — lands fair value near $230, ~35% above the price. Our call: BUY, 4/5. The reservation is a maturing growth story (next quarter's subscriber number could look bumpy on the rate-plan reset) and ~$75B of net debt, which is why it isn't 5/5. But the best network in America went on sale on a sentiment wobble, and we're aligned with the Street's Buy (avg target ~$243, 45 of 54 analysts). Own it for the network moat and the cash, add on further fear toward the low $160s, and watch the subscriber trend. Not financial advice.

THE CALL: BUY (4/5, A WORLD-CLASS NETWORK ON SALE — A BEAT-AND-RAISE-ON-CASH PUNISHED FOR MERELY SLOWING GROWTH) — base-case value ~$230 vs ~$170 today.

What to watch: evidence the growth slowdown is temporary — postpaid account adds re-accelerating after the Q3 rate-plan modernization, broadband and U.S. Cellular synergies flowing through, and Adjusted Free Cash Flow marching toward $20B — which would re-rate the stock back toward the Street's ~$243 target; the risk to respect is a genuine price war with Verizon and AT&T, postpaid phone net adds rolling over, or churn climbing well beyond this quarter's blip, which combined with ~$75B of net debt could push a maturing growth name down toward a boring, high-yield telecom multiple

Also on YouTube: @ChargedAlpha

DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.